Our research involves the application of nutrition and nutrigenetics to the nutraceutical prevention and post-onset management of type 2 diabetes in humans, with a view to the reduction of polypharmacy.
Provides large-scale proteome identification (including PTM) and quantification analysis, targeted analysis of proteins, and has a platform setup for efficient metaproteomics analysis